Skip to content

Contact +44 (0) 20 7060 7474 email us

Diabetes

Hemoglobin A1c Monitoring

Global Market Trends

Publication Date November 2009
Publisher BizAcumen
Product Type Report
Pages 109
ISBN Number not applicable
Product Code BIZ00020

Price

£1,980.00
approximately: $2,998 | €2,210

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

The seriousness of affliction and the need for effective therapy to manage diabetes has led to the emergence of a significant market for monitoring the treatment efficiency of the disease. Other factors such as greater glucose control, product innovations that help improve compliance or convenience comprise other growth drivers in hemoglobin A1C monitoring market.

Diabetes patients (Type I) who regularly monitor their HbA1c (hemoglobin A1C) levels attain tight glucose control, thus considerably reducing their vulnerability to a cardiovascular disease. High blood sugar level for a longer period of time could result to increase in risk of heart disease or stroke. An HBA1C level more that 4.6 indicate the person is at increased risk for heart attack. The ADA (American Diabetes Association), recommends an HbA1c test every 3 to 6 months for monitoring the levels of blood sugar in insulin-administered patients, patients with high blood glucose levels and patients with a change of therapy.

These and other market data and trends are presented in "Hemoglobin A1c Monitoring: Global Market Trends" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Contents

  • 1.Methodology
    • Study Reliability and Reporting Limitations
    • Disclaimers
    • Quantitative Techniques & Reporting Level
  • 2.Market Overview
    • Diabetes Monitoring Market
    • Higher Levels of Glycosylated Hemoglobin Increases The Risk of Death
    • Regular Hba1c Test Keeps Heart Risk at Bay
    • Home Monitoring
  • 3.Product Facts
    • Hba1c Laboratory Testing
    • Hba1c Point of Care Testing & Self- Monitoring
  • 4.Technological Developments
    • New Noninvasive Monitoring and Testing Devices
    • Hgi as A Statistical Predictor of Nephropathy and Retinopathy
    • Micro-Optical Detection Method Technology - Metrika
  • 5.Regulatory Environment
    • Animas Obtains Fda Approval for Onetouch Glucose Management System
    • Arkray USA Obtains Fda Approval for Glucocard
    • Bayer's Breeze Blood Glucose Monitoring System Receives Commendation
    • Trinity Biotech Obtains Fda Approval for Point of Care Hba1c Test
    • Medapps Receives Fda Clearance for Otc Use of D-Pal Remote System
    • Dexcom Receives Fda Approval for Sts-7 System
    • Diazyme's Direct Enzymatic Hba1c Assay Kit Receives Fda Clearance
    • Trinity Biotech Receives Fda Approval for Tristat Hba1c Test
  • 6.Corporate Developments
    • Roche Inks Marketing Agreement with Mankind Pharma
    • Nicholas Piramal Forms Joint Venture with Arkray
    • Quotient Diagnostics to Commence Production of Quo-Test System
    • Pelikan and Eli Lilly Sign Co-Promotion Agreement
    • Quantimetrix Develops Glycohemosure
    • Olympus Life Science Europa Unveils Hba1c Assay
    • Siemens Healthcare Introduces Dca VantageAnalyser
    • Sysmex America and Bio-Rad Sign Long-Term Distribution Agreement
    • Medtronic Enters in to Alliance with Bayer Healthcare
    • Inverness Snaps up Cholestech
    • Iq Micro to Complete Lifecare Acquisition
    • Bio-Rad Introduces The In2it Analyzer
    • Abbott Diabetes Launches Freestyle LiteBlood Glucose Meter
    • Bayer Introduces Breeze2 and Contour Blood Glucose Meters
    • Arkray Introduces Pocketchemz Blood Glucose Monitoring System
    • Abbott Rolls out New Blood Glucose Monitoring Devices
    • Axis-Shield UK Introduces Afinion/li>
    • Medtronic Plans Launch of Online Testing Kit for Diabetes
    • Nova Biomedical Launches Nova MaxBlood Glucose Monitoring System
    • Medtronic Announces Launch of New Continuous Glucose Monitoring System
    • Lifescan Offers Meter Upgrade for Onetouch Blood Glucose Monitoring Systems
  • 7.Major Players
    • Abbott Laboratories (USA)
    • Axis-Shield (UK)
    • Bayer Healthcare Diabetes Care (USA)
    • Beckman Coulter, Inc. (USA)
    • Bio-Rad Laboratories Inc (USA)
    • Biosafe Laboratories Inc (USA)
    • Diabetes Technologies Inc (USA)
    • Flexsite Diagnostics Inc (USA)
    • Primus Diagnostics (USA)
    • Roche Diagnostics (Switzerland)
    • Tosoh Bioscience, Inc (USA)
  • 8.Global Market Analytics
  • 9.The United States
    • An Insight
    • Market Highlights
    • Challenges in The Hba1c Monitoring Market in The US
    • Market Trends & Issues
    • Impact of Pricing and Innovation
    • Hba1c Monitoring vs Blood Glucose Monitoring
    • Impact of Diabetes Education Campaigns on Hba1c Monitors Usage
    • Impact of Sedentary Lifestyle
    • Reimbursements from Managed Care Organizations
    • The Diabetes A1c Initiative/li>
    • 10.Canada
  • 11.Japan
  • 12.Europe
    • A.France
    • B.Germany
    • C.Italy
    • D.The United Kingdom
    • E.Spain
    • F.Russia
    • G.Rest of Europe
  • 13.Asia-Pacific
  • 14.Middle East
  • 15.Latin America
  • 16.Rest of World
  • Exhibits
    • Table 1: Global Hba1c Monitoring Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 2: Percentage Breakdown of Global Hba1c Monitoring Market by Region for The Years 2008 &
    • Table 3: Global Hba1c Laboratory Testing Market by Region for The Period 2007- 2015 (Sales in US$ Million)
    • Table 4: Percentage Breakdown of Global Hba1c Laboratory Testing Market by Region for The Years 2008 &
    • Table 5: Global Hba1c Point of Care Testing & Self-Monitoring Market by Region for The Period 2007-2015 (Sales in US$ Million)
    • Table 6: Percentage Breakdown of Global Hba1c Point of Care Testing & Self- Monitoring Market by Region for The Years 2008 &
    • Table 7: Percentage Breakdown of Hba1c Point of Care Testing Equipment Manufacturer Revenues in The US -
    • Table 8: Percentage Breakdown of Hba1c Laboratory Testing Equipment Manufacturer Revenues in The US -
    • Table 9: The US Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 10: Percentage Breakdown of The US Market for Hba1c Monitoring by Type for The Years 2008 &
    • Table 11: The Canadian Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 12: Percentage Breakdown of The Canadian Market for Hba1c Monitoring by Type for The Years 2008 &
    • Table 13: The Japanese Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 14: Percentage Breakdown of The Japanese Market for Hba1c Monitoring by Type for The Years 2008 &
    • Table 15: Hba1c Monitoring Market by Region in Europe: 2007-2015 (Sales in US$ Million)
    • Table 16: Percentage Breakdown of Hba1c Monitoring Market by Region in Europe for The Years 2008 &
    • Table 17: The European Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 18: Percentage Breakdown of The European Market for Hba1c Monitoring by Type for The Years 2008 &
    • Table 19: The French Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 20: Percentage Breakdown of The French Market for Hba1c Monitoring by Type for The Years 2008 &
    • Table 21: The German Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 22: Percentage Breakdown of The German Market for Hba1c Monitoring by Type for The Years 2008 &
    • Table 23: The Italian Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 24: Percentage Breakdown of The Italian Market for Hba1c Monitoring by Type for The Years 2008 &
    • Table 25: The UK Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 26: Percentage Breakdown of The UK Market for Hba1c Monitoring by Type for The Years 2008 &
    • Table 27: The Spanish Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 28: Percentage Breakdown of Spanish Market for Hba1c Monitoring by Type for The Years 2008 &
    • Table 29: The Russian Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 30: Percentage Breakdown of Russian Market for Hba1c Monitoring by Type for The Years 2008 &
    • Table 31: The Rest of Europe Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 32: Percentage Breakdown of Rest of Europe Market for Hba1c Monitoring by Type for The Years 2008 &
    • Table 33: The Asia-Pacific (Excluding Japan) Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 34: Percentage Breakdown of Asia- Pacific (Excluding Japan) Market for Hba1c Monitoring by Type for The Years 2008 &
    • Table 35: The Middle East Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 36: Percentage Breakdown of Middle East Market for Hba1c Monitoring by Type for The Years 2008 &
    • Table 37: The Latin American Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 38: Percentage Breakdown of Latin American Market for Hba1c Monitoring by Type for The Years 2008 &
    • Table 39: The Rest of World Market for Hba1c Monitoring by Type: 2007-2015 (Sales in US$ Million)
    • Table 40: Percentage Breakdown of Rest of World Market for Hba1c Monitoring by Type for The Years 2008 &
  • Companies Profiled